Catalytic Matching Funds

Matching Funds are designed to inspire innovation and ambitious, evidence-based programming approaches to increase impact in specific strategic priority areas.

Below is a list of priority areas for the use of Matching Funds for the 2023-2025 allocation period. Funding levels will be published following the Seventh Replenishment, and will depend on available funds.

  • HIV: Prevention for key populations, adolescent girls and young women, and their sexual partners.
  • TB: Find and successfully treat the missing people with drug-susceptible and drug-resistant tuberculosis (TB).
  • TB: Scale up TB prevention.
  • TB: Country readiness for innovation and quality TB programming.
  • Malaria: Malaria elimination in Southern Africa.
  • RSSH: Scaling-up programs that remove human rights and gender-related barriers.
  • RSSH: Incentivizing RSSH quality and scale.
  • RSSH: Effective community systems and responses that contribute to improved health outcomes, and equitable access to integrated people-centered quality services.
  • RSSH: Equitable access to quality health products through innovation, partnership, and promoting sustainable sourcing and supply chains at global, national, and community levels (NextGen Market Shaping).
Our 2023-2025 allocation period webinar series includes a session on catalytic matching funds. Learn more and register

Applicants eligible for Matching Funds in the 2023-2025 allocation period will be notified in the allocation letters sent to countries at the end of 2022. In order to access Matching Funds, applicants must meet specific conditions on how funds are budgeted towards the Matching Funds priority areas, as outlined in the allocation letters. Technical assistance will be available to help countries get the most impact from Matching Funds.

Trackers, FAQs and guidance notes on Matching Funds for the 2023-2025 allocation period will be shared on this page starting in December 2022.

  • 2020-2022 Matching Funds Tracker
    download in English